Cannara Biotech Inc (LOVE) — Financial Flexibility Index
Cannara Biotech Inc (LOVE) has a Financial Flexibility Index of 0.20x as of November 2025. Free cash flow of CA$12.58 Million (operating CF CA$7.96 Million minus capex CA$4.62 Million) represents 0% of total liabilities (CA$62.63 Million). Check strategic asset allocation of Cannara Biotech Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cannara Biotech Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Cannara Biotech Inc across 8 annual periods. See working capital position of Cannara Biotech Inc to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Cannara Biotech Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Cannara Biotech Inc. For the full company profile including market capitalisation, see LOVE company net worth.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.40x | CA$26.37 Million | CA$20.01 Million | CA$66.43 Million | ▲ +46.0% |
| 2024 | 0.27x | CA$18.15 Million | CA$10.68 Million | CA$66.77 Million | ▲ +6.4% |
| 2023 | 0.26x | CA$15.79 Million | CA$5.91 Million | CA$61.78 Million | ▲ +66.9% |
| 2022 | 0.15x | CA$9.02 Million | CA$-6.08 Million | CA$58.88 Million | ▼ -85.0% |
| 2021 | 1.02x | CA$28.51 Million | CA$-2.09 Million | CA$27.91 Million | ▲ +11872.3% |
| 2020 | -0.01x | CA$-143.08K | CA$-9.32 Million | CA$16.49 Million | ▼ -101.0% |
| 2019 | 0.86x | CA$15.60 Million | CA$-7.41 Million | CA$18.17 Million | ▼ -52.7% |
| 2018 | 1.81x | CA$25.61 Million | CA$-2.30 Million | CA$14.12 Million | — |